Status
Conditions
Treatments
About
The main objective of this project is to demonstrate the feasibility of DLSCT to detect breast cancer in women with dense breasts.
Patients with locoregional advanced primary breast cancer and heterogeneously (n = 7) or extremely dense breasts (n = 7) as determined by mammography will be included in this study. These patients have an indication for a positron emission tomography computed tomography (PET-CT) scan to search for distant metastases. In this study the participants will undergo an additional contrast enhanced DLSCT scan to determine the feasibility of spectral CT to detect breast cancer in women with dense breasts.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of histopathologically proven locoregional advanced primary breast cancer:
Heterogeneously or extremely dense breasts as described by visual assessment on full-field digital mammograms: category C or D according to the ACR BI-RADS lexicon
Exclusion criteria
Loading...
Central trial contact
Carla M Meeuwis, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal